CIK 0001228627
- Non-accelerated filer
- Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113516358
- Phone
- +1 984-884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,211,769
- in 7 filings, $50K under 10b5-1 plans
Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Foundation Fighting Blindness Retinal Degeneration Fund −$2.8M Director sold 15% of stake
- Gagnon Robert E. −$177K Chief Financial Officer sold 7% of stake
- Magrath George −$145K Chief Executive Officer sold 2% of stake
- YERXA BENJAMIN R −$117K President sold 5% of stake
- SCHACHLE JOSEPH K −$17K Chief Operating Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-11 | Pepose Jay Director | Grant or award | +41,143 | 180,458 | ||
| 2024-06-11 | Pepose Jay Director | Grant or award · Stock Option (Right to Buy) | +35,181 | 35,181 | ||
| 2024-04-11 | Pepose Jay Director | Grant or award | +32,000 | 139,315 | ||
| 2024-04-11 | Pepose Jay Director | Grant or award · Stock Option (right to buy) | +48,000 | 48,000 | ||
| 2024-01-01 | Pepose Jay Director | Grant or award | +14,964 | 107,315 | ||
| 2023-11-01 | Pepose Jay Director | Grant or award | +35,000 | 92,351 | ||
| 2023-06-06 | Pepose Jay Director | Grant or award | +10,976 | 57,351 | ||
| 2023-06-06 | Pepose Jay Director | Grant or award · Stock Option | +9,639 | 9,639 | ||
| 2023-04-19 | Pepose Jay Director | Grant or award | +468 | 46,375 | ||
| 2023-01-11 | Pepose Jay Director | Grant or award | +13,013 | 45,907 | ||
| 2023-01-10 | Pepose Jay Director | Grant or award · Stock Option (right to buy) | +33,291 | 33,291 | ||
| 2022-07-01 | Pepose Jay Director | Grant or award | +9,900 | 32,894 | ||
| 2022-06-13 | Pepose Jay Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-04-08 | Pepose Jay Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-12-13 | Pepose Jay Director | Purchase | +8,250 | $3.65 | $30K | 22,994 |
| 2021-09-13 | Pepose Jay Director | Purchase | +12,631 | $4.75 | $60K | 14,744 |
| 2021-06-07 | Pepose Jay Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 |
Page 1 of 1 · 17 trades